| Filed On | Filing |
|---|---|
| 09 Sep 2026 |
Form 4: Scheeren Joseph, Director
Returned 23,000 shares to the issuer · Disposed of 111,819 Share Option (Right to Buy) (Disposition to Issuer) |
| 09 Sep 2026 |
Form 4: Phillips Anne M., Director
Returned 3,000 shares to the issuer · Disposed of 111,819 Share Option (Right to Buy) (Disposition to Issuer) |
| 09 Sep 2026 |
Form 4: Morgon Pierre A., Director
Returned 10,506 shares to the issuer · Disposed of 132,213 Share Option (Right to Buy) (Disposition to Issuer) |
| 09 Sep 2026 |
Form 4: Hooftman Leon, Chief Medical Officer
Received 361,530 shares as a grant or award · Returned 361,530 shares to the issuer · Disposed of 335,166 Share Option (Right to Buy) (Disposition to Issuer) |
| 09 Sep 2026 |
Form 4: Wright Robin, Director
Returned 48,256 shares to the issuer · Disposed of 132,213 Share Option (Right to Buy) (Disposition to Issuer) |
| 09 Sep 2026 |
Form 4: Hammacher Alex, Director
Returned 3,000 shares to the issuer · Disposed of 111,819 Share Option (Right to Buy) (Disposition to Issuer) |
| 09 Sep 2026 |
Form 4: Enright William, Director
Returned 1,243,377 shares to the issuer · Disposed of 2,019,716 Share Option (Right to Buy) (Disposition to Issuer) |
| 09 Sep 2026 |
Form 4: Dawes Karen A, Director
Returned 1,700 shares to the issuer · Disposed of 111,819 Share Option (Right to Buy) (Disposition to Issuer) |
| 11 Jun 2025 |
Form 4: Scheeren Joseph, Director
Granted 20,174 Share Option (Right to Buy) |
| 11 Jun 2025 |
Form 4: Hammacher Alex, Director
Granted 20,174 Share Option (Right to Buy) |
| 11 Jun 2025 |
Form 4: Wright Robin, Director
Granted 20,174 Share Option (Right to Buy) |
| 11 Jun 2025 |
Form 4: Morgon Pierre A., Director
Granted 20,174 Share Option (Right to Buy) |
| 11 Jun 2025 |
Form 4: Phillips Anne M., Director
Granted 20,174 Share Option (Right to Buy) |
| 11 Jun 2025 |
Form 4: Dawes Karen A, Director
Granted 20,174 Share Option (Right to Buy) |
| 05 Feb 2025 |
Form 4: Enright William, Director
Granted 600,000 Share Option (Right to Buy) |
| 05 Feb 2025 |
Form 4: Griffiths Graham, Chief Business Officer
Granted 200,000 Share Option (Right to Buy) |
| 05 Feb 2025 |
Form 4: Hooftman Leon, Chief Medical Officer
Granted 140,000 Share Option (Right to Buy) |
| 05 Feb 2025 |
Form 4: Brown Gemma, Chief Financial Officer
Granted 160,000 Share Option (Right to Buy) |
| 18 Jun 2024 |
Form 4: Hooftman Leon, Chief Medical Officer
Granted 195,166 Share Option (Right to Buy) |
| 14 May 2024 |
Form 4: Morgon Pierre A., Director
Granted 19,516 Share Option (Right to Buy) |
Loading...
